Showing 161-170 of 1732 results for "".
Wise Investing
https://practicalneurology.com/columns/practice-management/wise-investing/30274/The key to building wealth during today's bull markets, bear markets, and corrections.The Multiple Sclerosis Prodrome: Past, Present, and Future
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/the-multiple-sclerosis-prodrome-past-present-and-future/31973/Multiple sclerosis may cause symptoms and disability prior to classically defined disease onset.Safety Monitoring of Disease-Modifying Therapies in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/safety-monitoring-of-disease-modifying-therapies-in-multiple-sclerosis/32085/Guidance in disease-modifying therapy selection and appropriate safety monitoring are important roles of the clinician caring for people with multiple sclerosis.Proposed Hospital Standards for Parkinson Disease Care Aim to Avoid Preventable Harm
https://practicalneurology.com/programs/practical-neurology/proposed-hospital-standards-for-parkinson-disease-care-aim-to-avoid-preventable-harm/35438/Preventable harm is a serious concern for patients with Parkinson disease who receive care in the hospital setting, even when admitted for reasons other than their diagnosis. Peter Pronovost, MD, PhD, FCCM, Chief Quality and Transformation Officer at University Hospitals Cleveland Medical Center, ClDoctors Betrayed By Traditional Financial Strategies, Part 2 of 2
https://practicalneurology.com/columns/practice-management/doctors-betrayed-by-traditional-financial-strategies-part-2-of-2/30446/- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/pn0907-dementia-pdf/31121/Anosognosia in Alzheimer’s Disease: Understanding Unawareness of Cognitive DeficitsAnosognosia, the lack of awareness of one’s own cognitive and functional impairments, is a significant challenge in managing Alzheimer’s Disease (AD). Research indicates that over half of AD patients exhibit partial o
- Using Botox to “Loosen” Spastic Muscleshttps://practicalneurology.com/diseases-diagnoses/neuromuscular/pn0807-botox-pdf/31132/Botulinum Toxin as an Effective Treatment for Post-Stroke SpasticityPost-stroke spasticity remains a significant challenge for approximately one-third of the 5.7 million stroke survivors in the United States, often leading to disabilities such as muscle weakness, incoordination, and altered muscle t
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN1107epilepsy-pdf/31101/Febrile seizures are a prevalent neurological concern in pediatric populations, affecting approximately 4% of children in the United States. Typically occurring between one month and five years of age, with a peak incidence at 18 to 22 months, these seizures are triggered by febrile illnesses rather
- A Century of Alzheimer's: Progress and Pitfallshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/pn1106-100years-pdf/31244/Alzheimer’s disease (AD), first identified by Alois Alzheimer in 1906 through the examination of Auguste D.’s brain, has evolved into one of the most extensively studied neurological disorders. Despite over a century of research, AD remains challenging to predict, diagnose accurately in living patie
- MS Diagnosis: Sizing Up the Suspectshttps://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/pn0205pg52-56-pdf/31493/Diagnosing multiple sclerosis (MS) remains one of the most challenging tasks in neurology due to its diverse clinical presentations and numerous mimicking conditions. In Jeffrey I. Greenstein’s February 2005 article in *Practical Neurology*, the complexities of differentiating MS from other neurolog